These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22433865)

  • 1. Toll-like receptor activation of human cells by synthetic triacylated lipid A-like molecules.
    Dunn-Siegrist I; Tissières P; Drifte G; Bauer J; Moutel S; Pugin J
    J Biol Chem; 2012 May; 287(20):16121-31. PubMed ID: 22433865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Toll-like receptors by Burkholderia pseudomallei.
    West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
    BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition.
    Erridge C; Kennedy S; Spickett CM; Webb DJ
    J Biol Chem; 2008 Sep; 283(36):24748-59. PubMed ID: 18559343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bordetella pertussis Lipid A Recognition by Toll-like Receptor 4 and MD-2 Is Dependent on Distinct Charged and Uncharged Interfaces.
    Maeshima N; Evans-Atkinson T; Hajjar AM; Fernandez RC
    J Biol Chem; 2015 May; 290(21):13440-53. PubMed ID: 25837248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of lipid A variants by the TLR4-MD-2 receptor complex.
    Maeshima N; Fernandez RC
    Front Cell Infect Microbiol; 2013; 3():3. PubMed ID: 23408095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Human Toll-like Receptor 4 (TLR4)·Myeloid Differentiation Factor 2 (MD-2) by Hypoacylated Lipopolysaccharide from a Clinical Isolate of Burkholderia cenocepacia.
    Di Lorenzo F; Kubik Ł; Oblak A; Lorè NI; Cigana C; Lanzetta R; Parrilli M; Hamad MA; De Soyza A; Silipo A; Jerala R; Bragonzi A; Valvano MA; Martín-Santamaría S; Molinaro A
    J Biol Chem; 2015 Aug; 290(35):21305-19. PubMed ID: 26160169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components.
    Dziarski R; Wang Q; Miyake K; Kirschning CJ; Gupta D
    J Immunol; 2001 Feb; 166(3):1938-44. PubMed ID: 11160242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanized TLR4/MD-2 mice reveal LPS recognition differentially impacts susceptibility to Yersinia pestis and Salmonella enterica.
    Hajjar AM; Ernst RK; Fortuno ES; Brasfield AS; Yam CS; Newlon LA; Kollmann TR; Miller SI; Wilson CB
    PLoS Pathog; 2012; 8(10):e1002963. PubMed ID: 23071439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria.
    Elson G; Dunn-Siegrist I; Daubeuf B; Pugin J
    Blood; 2007 Feb; 109(4):1574-83. PubMed ID: 17038528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postulates for validating TLR4 agonists.
    Manček-Keber M; Jerala R
    Eur J Immunol; 2015 Feb; 45(2):356-70. PubMed ID: 25476977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetraacylated lipid A and paclitaxel-selective activation of TLR4/MD-2 conferred through hydrophobic interactions.
    Resman N; Oblak A; Gioannini TL; Weiss JP; Jerala R
    J Immunol; 2014 Feb; 192(4):1887-95. PubMed ID: 24420921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of endotoxic principle of bacterial lipopolysaccharide and its recognition by the innate immune systems of hosts.
    Kusumoto S; Fukase K
    Chem Rec; 2006; 6(6):333-43. PubMed ID: 17304523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
    Okamoto N; Mizote K; Honda H; Saeki A; Watanabe Y; Yamaguchi-Miyamoto T; Fukui R; Tanimura N; Motoi Y; Akashi-Takamura S; Kato T; Fujishita S; Kimura T; Ohto U; Shimizu T; Hirokawa T; Miyake K; Fukase K; Fujimoto Y; Nagai Y; Takatsu K
    J Biol Chem; 2017 Sep; 292(37):15378-15394. PubMed ID: 28754693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From agonist to antagonist: structure and dynamics of innate immune glycoprotein MD-2 upon recognition of variably acylated bacterial endotoxins.
    DeMarco ML; Woods RJ
    Mol Immunol; 2011 Oct; 49(1-2):124-33. PubMed ID: 21924775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemistry of lipid A: at the heart of innate immunity.
    Molinaro A; Holst O; Di Lorenzo F; Callaghan M; Nurisso A; D'Errico G; Zamyatina A; Peri F; Berisio R; Jerala R; Jiménez-Barbero J; Silipo A; Martín-Santamaría S
    Chemistry; 2015 Jan; 21(2):500-19. PubMed ID: 25353096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide Lipid A Mimetics.
    Heine H; Adanitsch F; Peternelj TT; Haegman M; Kasper C; Ittig S; Beyaert R; Jerala R; Zamyatina A
    Front Immunol; 2021; 12():631797. PubMed ID: 33815382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of MD-2 in TLR2- and TLR4-mediated recognition of Gram-negative and Gram-positive bacteria and activation of chemokine genes.
    Dziarski R; Gupta D
    J Endotoxin Res; 2000; 6(5):401-5. PubMed ID: 11521063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative TLRs are stimulated by bacterial ligand to induce TLR2-unresponsive colon cell response.
    Mukherjee S; Biswas R; Biswas T
    Cell Signal; 2013 Aug; 25(8):1678-88. PubMed ID: 23665374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR4 agonists as immunomodulatory agents.
    Alderson MR; McGowan P; Baldridge JR; Probst P
    J Endotoxin Res; 2006; 12(5):313-9. PubMed ID: 17059695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological properties of the native and synthetic lipid A of Porphyromonas gingivalis lipopolysaccharide.
    Kumada H; Haishima Y; Watanabe K; Hasegawa C; Tsuchiya T; Tanamoto K; Umemoto T
    Oral Microbiol Immunol; 2008 Feb; 23(1):60-9. PubMed ID: 18173800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.